A new review reveals how focal adhesion kinase (FAK) acts as a central regulator of tumor progression and immune suppression ...

A research team at Leipzig University has identified a mechanism in adhesion G protein-coupled receptors (adhesion GPCRs), a ...

A long-standing mystery in cancer treatment is how tumor cells so often become resistant to drugs, even ones they have never encountered before.

Researchers at NYU Langone Health propose a model that could explain how cancer cells adapt to environmental stress, an ...

Twenty-one retrospective studies met the inclusion criteria. The overall pooled prevalence of L1CAM positivity was 15%. Stratified by molecular subtype, prevalence was the lowest in POLE-mutated ...

A new comprehensive review is shedding light on the expanding role of focal adhesion kinase (FAK) in cancer biology and its potential as a ...

The activated leukocyte cell adhesion molecule (ALCAM) is a critical member of the immunoglobulin superfamily that mediates both homotypic and heterotypic cell interactions. It plays a central role in ...

A new study published in PRX Life has identified hidden structural patterns inside the flow of living cells that appear to ...

Cells aren’t as passive as scientists once thought—they actively create internal currents to move proteins quickly and ...

Druggable phosphatases in cancer and immune cells, with examples of their corresponding drugs. Structures of allosteric inhibitors targeting PP2A, PRL3, DUSP1/6, and SHP2 in cancer cells (left).

Circulating tumor cells (CTCs) refer to cancer cells that have broken off from a primary tumor. These tumor cells can travel through the blood in the circulatory system and lodge themselves in other ...